Pharma BD Deal Intelligence
Bayer AG (Bayer HealthCare) / Algeta ASA
2009 · Licensing/Option · $800M · Complete
Announcement Sentiment
93
Strongly positive
Co-development/commercialization of radium-223 (Xofigo) for CRPC bone mets. ~$800M deal value. Source: Bayer/Algeta press, Norway business publications.
Key facts
Announced Sep 04, 2009 Deal value $800M Deal type Licensing/Option
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals
The Pharma Closeout — Deal Intelligence Database.
Announcement Sentiment and Outcome Score from sourced facts.Home ·
Deals ·
Methodology ·
About